Javascript must be enabled to continue!
Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing
View through CrossRef
Abstract
Background
The Preclinical Alzheimer Cognitive Composite (PACC) is a composite score which can detect the first signs of cognitive impairment, which can be of importance for research and clinical practice. It is designed to be administered in person; however, in-person assessments are costly, and are difficult during the current COVID-19 pandemic.
Objective
To assess the feasibility of performing the PACC assessment with videoconferencing, and to compare the validity of this remote PACC with the in-person PACC obtained previously.
Methods
Participants from the HEalth and Ageing Data IN the Game of football (HEADING) Study who had already undergone an in-person assessment were re-contacted and re-assessed remotely. The correlation between the two PACC scores was estimated. The difference between the two PACC scores was calculated and used in multiple linear regression to assess which variables were associated with a difference in PACC scores.
Findings
Of the 43 participants who were invited to this external study, 28 were re-assessed. The median duration in days between the in-person and the remote assessments was 236.5 days (7.9 months) (IQR 62.5). There was a strong positive correlation between the two assessments for the PACC score, with a Pearson correlation coefficient of 0·82 (95% CI 0·66, 0·98). The multiple linear regression found that the only predictor of the PACC difference was the time between assessments.
Interpretation
This study provides evidence on the feasibility of performing cognitive tests online, with the PACC tests being successfully administered through videoconferencing. This is relevant, especially during times when face-to-face assessments cannot be performed.
Springer Science and Business Media LLC
Title: Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing
Description:
Abstract
Background
The Preclinical Alzheimer Cognitive Composite (PACC) is a composite score which can detect the first signs of cognitive impairment, which can be of importance for research and clinical practice.
It is designed to be administered in person; however, in-person assessments are costly, and are difficult during the current COVID-19 pandemic.
Objective
To assess the feasibility of performing the PACC assessment with videoconferencing, and to compare the validity of this remote PACC with the in-person PACC obtained previously.
Methods
Participants from the HEalth and Ageing Data IN the Game of football (HEADING) Study who had already undergone an in-person assessment were re-contacted and re-assessed remotely.
The correlation between the two PACC scores was estimated.
The difference between the two PACC scores was calculated and used in multiple linear regression to assess which variables were associated with a difference in PACC scores.
Findings
Of the 43 participants who were invited to this external study, 28 were re-assessed.
The median duration in days between the in-person and the remote assessments was 236.
5 days (7.
9 months) (IQR 62.
5).
There was a strong positive correlation between the two assessments for the PACC score, with a Pearson correlation coefficient of 0·82 (95% CI 0·66, 0·98).
The multiple linear regression found that the only predictor of the PACC difference was the time between assessments.
Interpretation
This study provides evidence on the feasibility of performing cognitive tests online, with the PACC tests being successfully administered through videoconferencing.
This is relevant, especially during times when face-to-face assessments cannot be performed.
Related Results
Abstract 5988: A non-canonical CDK9 complex mediates endocycling in polyaneuploid cancer cell (PACC) state
Abstract 5988: A non-canonical CDK9 complex mediates endocycling in polyaneuploid cancer cell (PACC) state
Abstract
Once prostate cancer has spread from its primary site, treatment is limited to systemically administered therapy. While tumors initially respond to these th...
Pick a PACC: Comparing domain- specific- and general- cognitive composites in Alzheimer disease research
Pick a PACC: Comparing domain- specific- and general- cognitive composites in Alzheimer disease research
Balancing the evolution of longitudinal cognitive assessment with practical considerations like maintaining legacy measures presents a vexing problem for many Alzheimer's Disease R...
Abstract 1795: Molecular vulnerabilities of the polyaneuploid cancer cell state
Abstract 1795: Molecular vulnerabilities of the polyaneuploid cancer cell state
Abstract
Once cancer has metastasized it remains incurable owing to resistance to nearly all systemic therapies. Classical views of therapeutic resistance include tu...
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Abstract— Alzheimer's disease is a neurodegenerative disease that develops gradually, and is associated with cardiovascular and cerebrovascular problems. Alzheimer's is a serious d...
Leveraging videoconferencing supports the continuity of Alzheimer research during the COVID‐19 pandemic and beyond
Leveraging videoconferencing supports the continuity of Alzheimer research during the COVID‐19 pandemic and beyond
AbstractBackgroundThe COVID‐19 pandemic has placed a demand on researchers to limit in‐person contact with participants, greatly impacting Alzheimer Disease (AD) research. To addre...
Association of baseline dementia stage with cognitive markers during follow‐up in patients with dementia of Alzheimer type with and without post‐mortem Alzheimer pathology
Association of baseline dementia stage with cognitive markers during follow‐up in patients with dementia of Alzheimer type with and without post‐mortem Alzheimer pathology
AbstractBackgroundPrediction of the course of cognitive function is of central importance in the care of patients with dementia of Alzheimer type (DAT) for individual management, c...
Abstract 1690: Myc suppression permits entry into the cancer endocycle to evade toxic effects of chemotherapy
Abstract 1690: Myc suppression permits entry into the cancer endocycle to evade toxic effects of chemotherapy
Abstract
Recent advances in precision medicine and immunotherapy have made great strides in cancer treatment and care, but chemoresistance remains a major challenge....
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
AbstractUnder the ATN framework, cerebrospinal fluid analytes provide evidence of the presence or absence of Alzheimer’s disease pathological hallmarks: amyloid plaques (A), phosph...

